Status:
COMPLETED
Platelet Rich Plasma on Osteoarthritis of Knee
Lead Sponsor:
Yung-Tsan Wu
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
35-75 years
Phase:
NA
Brief Summary
Although few studies have showed beneficial effect of platelet rich plasma (PRP) for osteoarthritis of knee (OA knee), only one study applied randomized, control method and none of them has the object...
Detailed Description
Patients with bilateral OA knee will be enrolled and randomized into intervention and control knee. One dose of PRP is applied in the intervention knee and normal saline in control side. Outcome measu...
Eligibility Criteria
Inclusion
- Age between 35 to 75 y/o.
- Alert consciousness
- Symptom of knee osteoarthritis persist at least 6 months and stage I or II scored by Ahlbäck grading system
- The pain score measured by VAS at least 4 points
Exclusion
- Has received hyaluronic acid or steroid injection within 6 monts
- Has received NSAIDs or steroid within one week
- Tumor or metastasis surrounding the knee joint
- Has received total knee replacement, major surgery in knee, rheumatoid arthritis
- Patient who cant tolerance the balance or muscle strength test.
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02239029
Start Date
August 1 2014
End Date
October 1 2016
Last Update
December 6 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tri-Service General Hospital, National Defense Medical Center,
Taipei, Neihu District, Taiwan, 886